Cargando…

Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care

Introduction: Real-world data indicate disparities in biologic access across Europe. Objectives: To describe the national structure of PsA care in Poland, with a particular focus on the population of inadequate responders (IRs) and difficulties associated with biologic therapy access. Methods: A poo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batko, Bogdan, Kucharz, Eugeniusz, Stajszczyk, Marcin, Brzosko, Marek, Samborski, Włodzimierz, Żuber, Zbigniew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465653/ https://www.ncbi.nlm.nih.gov/pubmed/34575217 http://dx.doi.org/10.3390/jcm10184106

Ejemplares similares

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Biosimilar switching – current state of knowledge
por: Wiland, Piotr, et al.
Publicado: (2018)

Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
por: Stajszczyk, Marcin, et al.
Publicado: (2023)

Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
por: Batko, Bogdan, et al.
Publicado: (2019)

Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
por: Moskal, Mateusz, et al.
Publicado: (2022)

Patient-Centered Care in Psoriatic Arthritis—A Perspective on Inflammation, Disease Activity, and Psychosocial Factors
por: Batko, Bogdan
Publicado: (2020)

The perspective of Polish patients with rheumatoid arthritis – treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study)
por: Stajszczyk, Marcin, et al.
Publicado: (2023)

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
por: Świerkot, Jerzy, et al.
Publicado: (2018)

Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis
por: Batko, Bogdan
Publicado: (2021)

Sacroiliac joint pain as an important element of psoriatic arthritis diagnosis
por: Krawczyk-Wasielewska, Agnieszka, et al.
Publicado: (2013)

Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient
por: Mojs, Ewa, et al.
Publicado: (2018)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Batko, Bogdan, et al.
Publicado: (2017)

Real-world burden of comorbidities in US patients with psoriatic arthritis
por: Shah, Kamal, et al.
Publicado: (2017)

The 33(rd) World Congress of Internal Medicine: Nusa Dua, Indonesia, August 22–25, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2016)

Real‐World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2023)

Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2015)

Medication persistence for psoriatic arthritis in a Brazilian real-world setting
por: Ribeiro da Silva, Michael Ruberson, et al.
Publicado: (2019)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
por: Elliott, Ashley, et al.
Publicado: (2019)

Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
por: Alegre-Sancho, Juan José, et al.
Publicado: (2023)

Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2016)

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2023)

New Insights on Juvenile Psoriatic Arthritis
por: Brunello, Francesco, et al.
Publicado: (2022)

From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
por: Zabotti, Alen, et al.
Publicado: (2020)

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan
por: Fujita, Hideki, et al.
Publicado: (2020)

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
por: Grellmann, Claudia, et al.
Publicado: (2020)

How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world study
por: Jawad, Issrah I., et al.
Publicado: (2022)

Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
por: Braña, Ignacio, et al.
Publicado: (2023)

Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)
por: Leeb, Burkhard F, et al.
Publicado: (2015)

Trials and tribulations in managing a complex case of psoriatic arthritis—a success story in the real world
por: Devarakonda, Aneela, et al.
Publicado: (2021)

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
por: Elgaard, Cathrine Dawn Büttner, et al.
Publicado: (2023)

Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
por: Joven, Beatriz, et al.
Publicado: (2023)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
por: Tektonidou, Maria G., et al.
Publicado: (2020)

Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice
por: Atzeni, Fabiola, et al.
Publicado: (2022)

In memoriam Professor Ugo Efisio Francesco Carcassi
por: Kucharz, Eugeniusz J.
Publicado: (2016)

Sesquicentennial of the birth of Edmund Faustinus Biernacki, a discoverer of the erythrocyte sedimentation rate
por: Kucharz, Eugeniusz J.
Publicado: (2017)

The 11(th) Central European Congress of Rheumatology: Prague, December 8–10, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2017)

Medical eponyms from linguistic and historical points of view
por: Kucharz, Eugeniusz Józï
Publicado: (2020)

Hit two birds with one stone: why crystalline glucosamine sulphate used for osteoarthritis medication is beneficial for patients with risk of cardiovascular disorders
por: Kucharz, Eugeniusz J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_epgopov85s9k845po08g2fkd7o